Bristol-Myers Squibb sees highest filings and grants during August in Q3 2023

Bristol-Myers Squibb has been focused on protecting inventions in United States(US) with 100 publications in Q3 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 28% filings and 16% grants. The United States(US), European Patent Office (E/P), China(CN), and World Intellectual Property Organization(WIPO) (WO) patent Office are among the top ten patent offices where Bristol-Myers Squibb is filings its patents. Among the top granted patent authorities, Bristol-Myers Squibb has 20% of its grants in European Patent Office (E/P), 16% in United States(US), and 11% in China(CN).

Amgen could be the strongest competitor for Bristol-Myers Squibb

In terms of grant share, Bristol-Myers Squibb stands in one position among its competitors. Amgen and johnson & johnson secured the top positions according to recent patent publication data.

Patents related to rare diseases and climate change lead Bristol-Myers Squibb’s portfolio

Bristol-Myers Squibb has the highest number of patents in rare diseases followed by, climate change and cell & gene therapy. For rare diseases, nearly 45% of patents were filed and 70% of patents were granted in Q3 2023.

Lung cancer related patents lead Bristol-Myers Squibb portfolio followed by lymphoma, and prostate cancer

Bristol-Myers Squibb has highest number of patents in lung cancer followed by lymphoma, prostate cancer, multiple myeloma (kahler disease) and melanoma. For lung cancer, nearly 2% of patents were filed and 2% of patents were granted in Q3 2023.

For comprehensive analysis of Bristol-Myers Squibb‘s filings and grants, buy the databook here.

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.